-
I agree FPH looks expensive, but on a casflow basis (of the company, not the share), it still stacks up at a 7% discount rate...which is not awful for what is becoming a low-risk company. MFT is at slightly better than that. I don't think there's much upside relative to market, but there's no downside either.
Certainly, I'd still rather be banking on these two internationally diversified companies compared yo the gentailers he was advocating...
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks